FLT3-ITD Mutation
8 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Combination of BTK Inhibitor Overcomes Drug-resistance in Refractory/Relapsed FLT3 Mutant AML (NCT03642236) | Nanfang Hospital, Southern Medical University | 2018-08-01 |
| Italian Non-Interventional Study of FLT3 Mutated AML Patients (NCT03547258) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2018-07-18 |
| Combination of Quizartinib and Omacetaxine Mepesuccinate for AML Carrying FLT3-ITD (NCT03135054) | The University of Hong Kong | 2017-10-01 |
| Combination of Sorafenib and Omacetaxine Mepesuccinate in Newly Diagnosed or Relapsed/Refractory AML Carrying FLT3-ITD (NCT03170895) | The University of Hong Kong | 2017-07-01 |
| Sorafenib to Treat FLT3-ITD AML (NCT02156297) | The First Affiliated Hospital of Soochow University | 2014-06-01 |
| Using Sorafenib as a Salvage Treatment for Relapsed or Refractory Acute Myeloid Leukemia Carrying FLT3-ITD (NCT03622541) | The University of Hong Kong | 2010-11-15 |
| Individual Patient Compassionate Use of Crenolanib (NCT03620318) | Arog Pharmaceuticals, Inc. |
Track FLT3-ITD Mutation automatically
Every clearance here is in the API, with alerts when new ones post.